In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment

In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment

Despite aggressive treatment regimens based on surgery and radiochemotherapy, the prognosis of patients with grade IV glioblastoma multiforme (GBM) remains extremely poor, calling for alternative options such as immunotherapy. Immunological mechanisms including the Natural Killer Group 2 member D (N...

Полное описание

Библиографические подробности
Главные авторы: Guranda Chitadze, Charlotte Flüh, Elgar Susanne Quabius, Sandra Freitag-Wolf, Christian Peters, Marcus Lettau, Jaydeep Bhat, Daniela Wesch, Hans-Heinrich Oberg, Stefanie Luecke, Ottmar Janssen, Michael Synowitz, Janka Held-Feindt, Dieter Kabelitz
Формат: Статья
Язык:English
Опубликовано: Taylor & Francis Group 2017-11-01
Серии:OncoImmunology
Предметы:
dexamethasone
gamma/delta t cells
glioblastoma multiforme
nkg2d
Online-ссылка:http://dx.doi.org/10.1080/2162402X.2017.1358839

Internet

http://dx.doi.org/10.1080/2162402X.2017.1358839

Схожие документы